Outlook Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Outlook Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2016 to Q2 2024.
  • Outlook Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 23.2M shares, a 80.8% increase year-over-year.
  • Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 250M shares, a 18% increase from 2022.
  • Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 212M shares, a 38.9% increase from 2021.
  • Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 153M shares, a 110% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 23.2M +10.4M +80.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 14.3M +1.44M +11.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 260M +32.8M +14.4% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 250M +38.1M +18% Jul 1, 2023 Sep 30, 2023 10-K 2023-12-22
Q2 2023 12.8M -208M -94.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 12.8M -206M -94.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 227M +39.3M +20.9% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 212M +59.4M +38.9% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-22
Q2 2022 220M +52.1M +30.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 219M +68.3M +45.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 188M +66.4M +54.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 153M Jul 1, 2021 Sep 30, 2021 10-K 2022-12-29
Q2 2021 168M +77.7M +85.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 151M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 122M Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q2 2020 90.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q2 2018 34.5M +10.1M +41.3% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q1 2018 25.7M +2.01M +8.47% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-15
Q2 2017 24.4M +5.63M +29.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 23.7M +9.57M +67.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q2 2016 18.8M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 14.2M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.